The U.S. Food and Drug Administration (FDA) has released an outline of a prevention strategy that is under development to prevent Cronobacter sakazakii contamination of powdered infant formula.
The prevention strategy is being developed in response to the prolific recall of Abbott Nutrition powdered infant formula that occurred in February 2022. The formula in question was recalled after FDA investigators found insanitary conditions in Abbott Nutrition’s Sturgis, Michigan manufacturing facility, which possibly contributed to Cronobacter sakazakii infections in four infants.